Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
9.7%
% of LFSC's 31 holdings also in IBRN
7.3%
% of IBRN's 55 holdings also in LFSC
Overlap by Weight
Sector Drift (LFSC minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in LFSC |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
INTRA-CELLULAR THERAPIES INC | 6.0% | 4.6% | 4.6% |
|
SAREPTA THERAPEUTICS INC | 4.1% | 3.9% | 3.9% |
|
ACADIA PHARMACEUTICALS INC | 2.2% | 4.4% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
LFSC Overweight Relative to IBRN
|
RADNET INC | 8.8% |
|
INSMED INC | 6.0% |
|
WAVE LIFE SCIENCES LTD. | 6.0% |
 |
LIVANOVA PLC | 5.9% |
|
BLUEPRINT MEDICINES CORP. | 5.7% |
|
MERIT MEDICAL SYSTEMS INC | 5.3% |
|
NEOGENOMICS INC | 4.9% |
|
SOLENO THERAPEUTICS INC | 4.4% |
|
BRIDGEBIO PHARMA, INC. | 4.3% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 4.3% |
LFSC Underweight Relative to IBRN
|
PTC THERAPEUTICS INC | -6.0% |
|
SCHOLAR ROCK HOLDING CORP. | -5.5% |
 |
ALKERMES PLC | -4.6% |
 |
ARGENX SE ADR | -4.5% |
|
CATALYST PHARMACEUTICAL PART | -4.4% |
|
NEUROCRINE BIOSCIENCES INC | -4.3% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
|
SUPERNUS PHARMACEUTICALS INC | -3.8% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |
|
DYNE THERAPEUTICS INC | -3.2% |